MENU
+Compare
CGON
Stock ticker: NASDAQ
AS OF
Sep 2, 04:59 PM (EDT)
Price
$27.45
Change
+$0.63 (+2.35%)
Capitalization
2.04B

CGON CG Oncology Forecast, Technical & Fundamental Analysis

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer... Show more

CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CGON with price predictions
Aug 29, 2025

CGON in upward trend: price may jump up because it broke its lower Bollinger Band on August 11, 2025

CGON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 9 cases where CGON's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 28, 2025. You may want to consider a long position or call options on CGON as a result. In of 27 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CGON just turned positive on August 18, 2025. Looking at past instances where CGON's MACD turned positive, the stock continued to rise in of 19 cases over the following month. The odds of a continued upward trend are .

CGON moved above its 50-day moving average on August 26, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CGON crossed bullishly above the 50-day moving average on August 29, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 6 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CGON advanced for three days, in of 79 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CGON declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CGON entered a downward trend on August 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CGON’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.051) is normal, around the industry mean (19.823). P/E Ratio (0.000) is within average values for comparable stocks, (52.034). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.525). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. CGON's P/S Ratio (3333.333) is very high in comparison to the industry average of (321.242).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CGON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
400 Spectrum Center Drive
Phone
+1 949 409-3700
Employees
61
Web
https://www.cgoncology.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIBCX31.22-0.02
-0.06%
Thornburg Investment Income Builder C
CDEYX18.36-0.03
-0.16%
Columbia Intrinsic Value Institutional 3
PLBBX39.72-0.15
-0.38%
Plumb Balanced Investor
PIGRX16.89-0.12
-0.71%
Putnam International Value C
LIESX21.24-0.17
-0.79%
Franklin International Equity IS

CGON and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with SYRE. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
+0.39%
SYRE - CGON
60%
Loosely correlated
-1.38%
IDYA - CGON
60%
Loosely correlated
-1.52%
KYMR - CGON
56%
Loosely correlated
-1.32%
ACLX - CGON
55%
Loosely correlated
-1.22%
NUVL - CGON
55%
Loosely correlated
+0.74%
More